KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Inventory Average (2018 - 2025)

Alnylam Pharmaceuticals' Inventory Average history spans 8 years, with the latest figure at $79.1 million for Q4 2025.

  • For Q4 2025, Inventory Average rose 2.33% year-over-year to $79.1 million; the TTM value through Dec 2025 reached $79.1 million, up 2.33%, while the annual FY2025 figure was $80.6 million, 3.83% down from the prior year.
  • Inventory Average reached $79.1 million in Q4 2025 per ALNY's latest filing, up from $73.5 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $130.4 million in Q1 2023 to a low of $68.6 million in Q2 2025.
  • Average Inventory Average over 5 years is $89.8 million, with a median of $86.4 million recorded in 2022.
  • Peak YoY movement for Inventory Average: soared 58.2% in 2023, then decreased 29.79% in 2024.
  • A 5-year view of Inventory Average shows it stood at $92.1 million in 2021, then surged by 32.66% to $122.2 million in 2022, then dropped by 24.35% to $92.5 million in 2023, then dropped by 16.45% to $77.2 million in 2024, then grew by 2.33% to $79.1 million in 2025.
  • Per Business Quant, the three most recent readings for ALNY's Inventory Average are $79.1 million (Q4 2025), $73.5 million (Q3 2025), and $68.6 million (Q2 2025).